Anthem Biosciences Revenue

Anthem Biosciences had revenue of 9.84B INR in the half year ending March 31, 2025. This brings the company's revenue in the last twelve months to 20.55B, up 31.84% year-over-year. In the fiscal year ending March 31, 2025, Anthem Biosciences had annual revenue of 18.50B with 30.29% growth.

Revenue (ttm)

20.55B

Revenue Growth

+31.84%

P/S Ratio

22.54

Revenue / Employee

10.47M

Employees

1,825

Market Cap

463.30B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	18.50B	4.30B	30.29%
Mar 31, 2024	14.20B	3.62B	34.24%
Mar 31, 2023	10.58B	-1.83B	-14.74%
Mar 31, 2022	12.41B	1.35B	12.24%
Mar 31, 2021	11.05B	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Sun Pharmaceutical Industries	537.77B
Divi's Laboratories	96.52B
Cipla	274.80B
Apollo Hospitals Enterprise	217.94B
Mankind Pharma	129.10B
Zydus Lifesciences	232.42B
Fortis Healthcare	80.94B
Aurobindo Pharma	320.25B

Revenue Rankings